← FDA DRUG APPROVALS

FDA ANDA · ANDA204351

SODIUM FLUORIDE F 18

sodium fluoride f-18

Sponsor: BIOMEDCL RES FDN

APPLICATION
ANDA204351
TYPE
ANDA
ORIGINAL APPROVAL
2015-01-09
LATEST ACTION
2015-01-09
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

SODIUM FLUORIDE F-18Prescription
SODIUM FLUORIDE F-18 10-200mCi/ML · INJECTABLE · INTRAVENOUS

Approval history

2015-01-09UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →